| Date Filed | Type | Description |
| 02/12/2021 |
SC 13G/A
| Robins David C. reports a 12.1% stake in TetraLogic Pharmaceuticals Corporation |
| 02/15/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/27/2018 |
3
| Robins David C. (10% Owner) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS Corp |
| 09/19/2017 |
SC 13G/A
| Robins David C. reports a 12.1% stake in TetraLogic Pharmaceuticals Corporation |
| 09/18/2017 |
SC 13G/A
| Robins David C. reports a 10.9% stake in TetraLogic Pharmaceuticals Corporation |
| 08/30/2017 |
SC 13G/A
| Robins David C. reports a 7.7% stake in TetraLogic Pharmaceuticals Corporation |
| 08/17/2017 |
SC 13G/A
| Robins David C. reports a 6.7% stake in TetraLogic Pharmaceuticals Corporation |
| 08/04/2017 |
SC 13G
| Robins David C. reports a 5.8% stake in TetraLogic Pharmaceuticals Corporation |
| 12/02/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 12/01/2016 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/22/2016 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
| 11/22/2016 |
8-K
| Quarterly results |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| NOMURA SECURITIES INTERNATIONAL, INC. (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of convertible notes
@ $0
Acquired 892,850 options to buy
@ $0
Acquired convertible notes
@ $0 |
|
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| GEODE CAPITAL MANAGEMENT LP (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 1,257,144 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
4
| TELEMETRY SECURITIES, L.L.C. (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 838,094 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
4
| LINDEN ADVISORS LP (See Remarks) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Disposed of options to buy
@ $0
Acquired 2,095,239 options to buy
@ $0
Acquired options to buy
@ $0 |
|
| 11/14/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/14/2016 |
3
| NOMURA SECURITIES INTERNATIONAL, INC. (See Remarks) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS CORP |
| 11/14/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/14/2016 |
3
| GEODE CAPITAL MANAGEMENT LP (See Remarks) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS CORP |
| 11/14/2016 |
3
| TELEMETRY SECURITIES, L.L.C. (See Remarks) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS CORP |
| 11/14/2016 |
3
| LINDEN ADVISORS LP (See Remarks) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS CORP |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/14/2016 |
3
| HIGHBRIDGE CAPITAL MANAGEMENT LLC (See Remarks) has filed a Form 3 on TETRALOGIC PHARMACEUTICALS CORP |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/14/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/14/2016 |
SC 13D
| TETRALOGIC PHARMACEUTICALS CORP reports a 0% stake in TetraLogic Pharmaceuticals Corporation |
| 11/14/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 11/14/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
|